Lets see we can rely upon Xolis report received from an unidentified hearsay source from information from an insider under a supposed quiet period that all is well with firm, or we can recognize complete dead silence of firm on all activity for four months despite stockholder outrage with no signs of large investor interest showing on pps, and note the "red flags" of eviction and vacation of company U.S. offices, and possible I.R.S. and state tax liens.
By the way, I remember quite a way back when Joe in investor conference gave assurance that NASDAQ listing was on the way despite stock value falling below $1 claiming GNBT had right to price exception of $1/$3 minimum rule because it had once before been on Nasdaq. So much for that. Just one of many broken/unmet goals. .
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links